While investigation of the dynamics of antibody titers and virus clearance in COVID-19 patients is feasible in humans, exploring the dynamics of lung-resident CD8+ T cells in infected human subjects is not, as studies of human lungs are restricted to analyses of single biopsy/resection or post-autopsy samples. The gene discussed is CD8A; the disease is COVID-19.